Arnolds, David E.
Carey, Kyle A.
Braginsky, Lena
Holt, Roxane
Edelson, Dana P.
Scavone, Barbara M.
Churpek, Matthew
Funding for this research was provided by:
National Institute of General Medical Sciences,United States
Article History
Received: 1 November 2021
Accepted: 25 March 2022
First Online: 6 April 2022
Declarations
:
: The study was approved by the University of Chicago Institutional Review Board with a waiver of consent. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: Drs. Churpek and Edelson have a patent pending (ARCD. P0535US.P2) for risk stratification algorithms for hospitalized patients and have received research support from EarlySense (Tel Aviv, Israel). Dr. Edelson has received research support and honoraria from Philips Healthcare (Andover, MA) and has an ownership interest in AgileMD (Chicago, IL), which is developing products for risk stratification of hospitalized patients. Drs. Arnolds, Braginksy, Holt, Scavone, and Mr. Carey report no competing interests.